MannKind reported $835.6M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 4.34B 845M Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Halozyme Therapeutics USD 8.56B 905M May/2026
Insmed USD 15.56B 19.73B May/2026
Karyopharm Therapeutics USD 956M 821M May/2026
MacroGenics USD 102M 4M Dec/2025
MannKind USD 965M 208M May/2026
Merck USD 297.1B 35.84B Mar/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 147.4B 6.42B May/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Xencor USD 795M 98M May/2026